nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—ovarian cancer—uterine cancer	0.372	1	CtDrD
Paclitaxel—CYP19A1—uterine cancer	0.151	1	CbGaD
Paclitaxel—CYP1B1—Progesterone—uterine cancer	0.0272	0.0915	CbGbCtD
Paclitaxel—ABCB11—Progesterone—uterine cancer	0.0272	0.0915	CbGbCtD
Paclitaxel—ABCC10—Etoposide—uterine cancer	0.0224	0.0754	CbGbCtD
Paclitaxel—ABCC1—Progesterone—uterine cancer	0.0193	0.065	CbGbCtD
Paclitaxel—ABCC1—Dactinomycin—uterine cancer	0.0153	0.0516	CbGbCtD
Paclitaxel—ABCC10—Doxorubicin—uterine cancer	0.0153	0.0514	CbGbCtD
Paclitaxel—ABCC1—Epirubicin—uterine cancer	0.0111	0.0373	CbGbCtD
Paclitaxel—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0104	0.035	CbGbCtD
Paclitaxel—ABCG2—Dactinomycin—uterine cancer	0.0103	0.0345	CbGbCtD
Paclitaxel—CYP3A7—Progesterone—uterine cancer	0.00956	0.0321	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.00956	0.0321	CbGbCtD
Paclitaxel—ABCC1—Etoposide—uterine cancer	0.00866	0.0291	CbGbCtD
Paclitaxel—ABCB11—Doxorubicin—uterine cancer	0.00831	0.0279	CbGbCtD
Paclitaxel—CYP1B1—Doxorubicin—uterine cancer	0.00831	0.0279	CbGbCtD
Paclitaxel—ABCC2—Carboplatin—uterine cancer	0.00763	0.0257	CbGbCtD
Paclitaxel—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.00726	0.0244	CbGbCtD
Paclitaxel—CYP3A5—Progesterone—uterine cancer	0.00717	0.0241	CbGbCtD
Paclitaxel—ABCG2—Carboplatin—uterine cancer	0.0069	0.0232	CbGbCtD
Paclitaxel—CYP2C8—Progesterone—uterine cancer	0.0069	0.0232	CbGbCtD
Paclitaxel—ABCC2—Etoposide—uterine cancer	0.00641	0.0215	CbGbCtD
Paclitaxel—ABCC1—Doxorubicin—uterine cancer	0.0059	0.0198	CbGbCtD
Paclitaxel—ABCG2—Etoposide—uterine cancer	0.00579	0.0195	CbGbCtD
Paclitaxel—CYP2C9—Progesterone—uterine cancer	0.00481	0.0162	CbGbCtD
Paclitaxel—ABCB1—Progesterone—uterine cancer	0.00467	0.0157	CbGbCtD
Paclitaxel—ABCC2—Doxorubicin—uterine cancer	0.00437	0.0147	CbGbCtD
Paclitaxel—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00422	0.0142	CbGbCtD
Paclitaxel—ABCG2—Doxorubicin—uterine cancer	0.00395	0.0133	CbGbCtD
Paclitaxel—ABCB1—Dactinomycin—uterine cancer	0.0037	0.0124	CbGbCtD
Paclitaxel—CYP3A5—Etoposide—uterine cancer	0.00321	0.0108	CbGbCtD
Paclitaxel—CYP2C8—Etoposide—uterine cancer	0.00309	0.0104	CbGbCtD
Paclitaxel—CYP3A4—Progesterone—uterine cancer	0.0028	0.0094	CbGbCtD
Paclitaxel—CYP19A1—corpus luteum—uterine cancer	0.00257	0.063	CbGeAlD
Paclitaxel—ABCB1—Etoposide—uterine cancer	0.00209	0.00702	CbGbCtD
Paclitaxel—ABCB1—Doxorubicin—uterine cancer	0.00142	0.00479	CbGbCtD
Paclitaxel—CYP3A4—Etoposide—uterine cancer	0.00125	0.00421	CbGbCtD
Paclitaxel—CYP19A1—semen—uterine cancer	0.0012	0.0295	CbGeAlD
Paclitaxel—TUBB4B—oviduct—uterine cancer	0.00104	0.0255	CbGeAlD
Paclitaxel—CYP3A4—Doxorubicin—uterine cancer	0.000854	0.00287	CbGbCtD
Paclitaxel—MAP2—myometrium—uterine cancer	0.000553	0.0136	CbGeAlD
Paclitaxel—MAP4—uterine cervix—uterine cancer	0.000546	0.0134	CbGeAlD
Paclitaxel—MAP4—decidua—uterine cancer	0.00052	0.0128	CbGeAlD
Paclitaxel—MAP4—renal system—uterine cancer	0.000511	0.0125	CbGeAlD
Paclitaxel—TUBB1—decidua—uterine cancer	0.000509	0.0125	CbGeAlD
Paclitaxel—BCL2—epithelium—uterine cancer	0.000501	0.0123	CbGeAlD
Paclitaxel—BCL2—smooth muscle tissue—uterine cancer	0.000482	0.0118	CbGeAlD
Paclitaxel—BCL2—renal system—uterine cancer	0.000464	0.0114	CbGeAlD
Paclitaxel—MAP4—uterus—uterine cancer	0.000455	0.0112	CbGeAlD
Paclitaxel—BCL2—endometrium—uterine cancer	0.000449	0.011	CbGeAlD
Paclitaxel—MAP2—uterine cervix—uterine cancer	0.00043	0.0105	CbGeAlD
Paclitaxel—BCL2—uterus—uterine cancer	0.000414	0.0102	CbGeAlD
Paclitaxel—TUBB2B—myometrium—uterine cancer	0.000413	0.0101	CbGeAlD
Paclitaxel—MAP2—decidua—uterine cancer	0.00041	0.0101	CbGeAlD
Paclitaxel—MAP4—female reproductive system—uterine cancer	0.000409	0.01	CbGeAlD
Paclitaxel—TUBB—myometrium—uterine cancer	0.000391	0.00958	CbGeAlD
Paclitaxel—MAP2—endometrium—uterine cancer	0.000389	0.00954	CbGeAlD
Paclitaxel—TUBB2A—myometrium—uterine cancer	0.000388	0.00953	CbGeAlD
Paclitaxel—TUBB6—myometrium—uterine cancer	0.000383	0.0094	CbGeAlD
Paclitaxel—MAP2—mammalian vulva—uterine cancer	0.000376	0.00923	CbGeAlD
Paclitaxel—MAP4—female gonad—uterine cancer	0.000372	0.00913	CbGeAlD
Paclitaxel—BCL2—female reproductive system—uterine cancer	0.000372	0.00912	CbGeAlD
Paclitaxel—MAP4—vagina—uterine cancer	0.00037	0.00908	CbGeAlD
Paclitaxel—BCL2—female gonad—uterine cancer	0.000338	0.0083	CbGeAlD
Paclitaxel—ABCC10—myometrium—uterine cancer	0.000335	0.00823	CbGeAlD
Paclitaxel—TUBB4B—myometrium—uterine cancer	0.000333	0.00817	CbGeAlD
Paclitaxel—TUBB4A—uterine cervix—uterine cancer	0.000332	0.00815	CbGeAlD
Paclitaxel—SLCO1B3—vagina—uterine cancer	0.000324	0.00795	CbGeAlD
Paclitaxel—MAP2—female reproductive system—uterine cancer	0.000322	0.0079	CbGeAlD
Paclitaxel—TUBB2B—uterine cervix—uterine cancer	0.000321	0.00788	CbGeAlD
Paclitaxel—TUBB4A—renal system—uterine cancer	0.000311	0.00763	CbGeAlD
Paclitaxel—MAPT—lymph node—uterine cancer	0.000304	0.00747	CbGeAlD
Paclitaxel—TUBB—uterine cervix—uterine cancer	0.000304	0.00746	CbGeAlD
Paclitaxel—TUBB2A—uterine cervix—uterine cancer	0.000302	0.00742	CbGeAlD
Paclitaxel—TUBB6—epithelium—uterine cancer	0.000301	0.00738	CbGeAlD
Paclitaxel—TUBB2B—renal system—uterine cancer	0.0003	0.00737	CbGeAlD
Paclitaxel—TUBB6—uterine cervix—uterine cancer	0.000298	0.00732	CbGeAlD
Paclitaxel—TUBB—smooth muscle tissue—uterine cancer	0.000295	0.00725	CbGeAlD
Paclitaxel—TUBB2A—smooth muscle tissue—uterine cancer	0.000294	0.00721	CbGeAlD
Paclitaxel—MAP2—female gonad—uterine cancer	0.000293	0.00719	CbGeAlD
Paclitaxel—MAP2—vagina—uterine cancer	0.000291	0.00715	CbGeAlD
Paclitaxel—TUBB2B—endometrium—uterine cancer	0.00029	0.00713	CbGeAlD
Paclitaxel—TUBB6—smooth muscle tissue—uterine cancer	0.00029	0.00711	CbGeAlD
Paclitaxel—TUBB—decidua—uterine cancer	0.00029	0.0071	CbGeAlD
Paclitaxel—TUBB2A—decidua—uterine cancer	0.000288	0.00707	CbGeAlD
Paclitaxel—TUBB6—decidua—uterine cancer	0.000284	0.00697	CbGeAlD
Paclitaxel—TUBB2B—mammalian vulva—uterine cancer	0.000281	0.00689	CbGeAlD
Paclitaxel—TUBB6—renal system—uterine cancer	0.000279	0.00684	CbGeAlD
Paclitaxel—TUBB4A—uterus—uterine cancer	0.000277	0.00679	CbGeAlD
Paclitaxel—TUBB—endometrium—uterine cancer	0.000275	0.00674	CbGeAlD
Paclitaxel—TUBB2A—endometrium—uterine cancer	0.000273	0.00671	CbGeAlD
Paclitaxel—TUBB6—endometrium—uterine cancer	0.00027	0.00662	CbGeAlD
Paclitaxel—TUBB—mammalian vulva—uterine cancer	0.000266	0.00652	CbGeAlD
Paclitaxel—TUBB2A—mammalian vulva—uterine cancer	0.000265	0.00649	CbGeAlD
Paclitaxel—ABCC10—uterine cervix—uterine cancer	0.000261	0.00641	CbGeAlD
Paclitaxel—TUBB6—mammalian vulva—uterine cancer	0.000261	0.0064	CbGeAlD
Paclitaxel—TUBB4B—uterine cervix—uterine cancer	0.000259	0.00636	CbGeAlD
Paclitaxel—TUBB—uterus—uterine cancer	0.000253	0.00621	CbGeAlD
Paclitaxel—TUBB2A—uterus—uterine cancer	0.000252	0.00618	CbGeAlD
Paclitaxel—TUBB4B—smooth muscle tissue—uterine cancer	0.000252	0.00618	CbGeAlD
Paclitaxel—TUBB4A—female reproductive system—uterine cancer	0.000249	0.00611	CbGeAlD
Paclitaxel—ABCC10—decidua—uterine cancer	0.000249	0.0061	CbGeAlD
Paclitaxel—TUBB6—uterus—uterine cancer	0.000249	0.0061	CbGeAlD
Paclitaxel—TUBB4B—decidua—uterine cancer	0.000247	0.00606	CbGeAlD
Paclitaxel—ABCC10—renal system—uterine cancer	0.000244	0.00599	CbGeAlD
Paclitaxel—TUBB4B—renal system—uterine cancer	0.000242	0.00595	CbGeAlD
Paclitaxel—TUBB2B—female reproductive system—uterine cancer	0.000241	0.0059	CbGeAlD
Paclitaxel—MAP4—lymph node—uterine cancer	0.000239	0.00587	CbGeAlD
Paclitaxel—ABCC1—myometrium—uterine cancer	0.000237	0.00582	CbGeAlD
Paclitaxel—ABCC10—endometrium—uterine cancer	0.000236	0.00579	CbGeAlD
Paclitaxel—TUBB4B—endometrium—uterine cancer	0.000234	0.00575	CbGeAlD
Paclitaxel—ABCC10—mammalian vulva—uterine cancer	0.000228	0.0056	CbGeAlD
Paclitaxel—TUBB4B—mammalian vulva—uterine cancer	0.000227	0.00556	CbGeAlD
Paclitaxel—TUBB4A—female gonad—uterine cancer	0.000227	0.00556	CbGeAlD
Paclitaxel—TUBB2A—female reproductive system—uterine cancer	0.000227	0.00556	CbGeAlD
Paclitaxel—TUBB6—female reproductive system—uterine cancer	0.000223	0.00548	CbGeAlD
Paclitaxel—TUBB2B—female gonad—uterine cancer	0.000219	0.00537	CbGeAlD
Paclitaxel—TUBB2B—vagina—uterine cancer	0.000218	0.00534	CbGeAlD
Paclitaxel—ABCC10—uterus—uterine cancer	0.000218	0.00534	CbGeAlD
Paclitaxel—BCL2—lymph node—uterine cancer	0.000218	0.00534	CbGeAlD
Paclitaxel—TUBB4B—uterus—uterine cancer	0.000216	0.0053	CbGeAlD
Paclitaxel—TUBB—female gonad—uterine cancer	0.000207	0.00508	CbGeAlD
Paclitaxel—TUBB2A—female gonad—uterine cancer	0.000206	0.00506	CbGeAlD
Paclitaxel—TUBB—vagina—uterine cancer	0.000206	0.00505	CbGeAlD
Paclitaxel—TUBB2A—vagina—uterine cancer	0.000205	0.00503	CbGeAlD
Paclitaxel—TUBB6—female gonad—uterine cancer	0.000203	0.00499	CbGeAlD
Paclitaxel—TUBB6—vagina—uterine cancer	0.000202	0.00496	CbGeAlD
Paclitaxel—CYP1B1—smooth muscle tissue—uterine cancer	0.0002	0.00489	CbGeAlD
Paclitaxel—CYP19A1—endometrium—uterine cancer	0.000199	0.00487	CbGeAlD
Paclitaxel—ABCG2—myometrium—uterine cancer	0.000196	0.00482	CbGeAlD
Paclitaxel—ABCC2—renal system—uterine cancer	0.000196	0.00481	CbGeAlD
Paclitaxel—ABCC10—female reproductive system—uterine cancer	0.000196	0.0048	CbGeAlD
Paclitaxel—CYP1B1—decidua—uterine cancer	0.000196	0.0048	CbGeAlD
Paclitaxel—TUBB4B—female reproductive system—uterine cancer	0.000194	0.00476	CbGeAlD
Paclitaxel—CYP1B1—renal system—uterine cancer	0.000192	0.00471	CbGeAlD
Paclitaxel—MAP2—lymph node—uterine cancer	0.000188	0.00462	CbGeAlD
Paclitaxel—ABCC1—uterine cervix—uterine cancer	0.000185	0.00453	CbGeAlD
Paclitaxel—CYP19A1—uterus—uterine cancer	0.000183	0.00449	CbGeAlD
Paclitaxel—ABCC10—female gonad—uterine cancer	0.000178	0.00437	CbGeAlD
Paclitaxel—ABCC10—vagina—uterine cancer	0.000177	0.00434	CbGeAlD
Paclitaxel—TUBB4B—female gonad—uterine cancer	0.000177	0.00434	CbGeAlD
Paclitaxel—ABCC1—decidua—uterine cancer	0.000176	0.00432	CbGeAlD
Paclitaxel—TUBB4B—vagina—uterine cancer	0.000176	0.00431	CbGeAlD
Paclitaxel—CYP1B1—uterus—uterine cancer	0.000171	0.0042	CbGeAlD
Paclitaxel—ABCC1—endometrium—uterine cancer	0.000167	0.0041	CbGeAlD
Paclitaxel—CYP19A1—female reproductive system—uterine cancer	0.000165	0.00404	CbGeAlD
Paclitaxel—ABCC1—mammalian vulva—uterine cancer	0.000162	0.00396	CbGeAlD
Paclitaxel—ABCC2—female reproductive system—uterine cancer	0.000157	0.00385	CbGeAlD
Paclitaxel—ABCC1—uterus—uterine cancer	0.000154	0.00378	CbGeAlD
Paclitaxel—CYP1B1—female reproductive system—uterine cancer	0.000154	0.00377	CbGeAlD
Paclitaxel—ABCG2—uterine cervix—uterine cancer	0.000153	0.00375	CbGeAlD
Paclitaxel—CYP19A1—female gonad—uterine cancer	0.00015	0.00367	CbGeAlD
Paclitaxel—CYP2C8—renal system—uterine cancer	0.000147	0.00361	CbGeAlD
Paclitaxel—ABCG2—decidua—uterine cancer	0.000146	0.00357	CbGeAlD
Paclitaxel—TUBB4A—lymph node—uterine cancer	0.000146	0.00357	CbGeAlD
Paclitaxel—CYP2C8—endometrium—uterine cancer	0.000142	0.00349	CbGeAlD
Paclitaxel—CYP3A5—uterine cervix—uterine cancer	0.000142	0.00348	CbGeAlD
Paclitaxel—TUBB2B—lymph node—uterine cancer	0.000141	0.00345	CbGeAlD
Paclitaxel—CYP1B1—female gonad—uterine cancer	0.00014	0.00343	CbGeAlD
Paclitaxel—ABCG2—endometrium—uterine cancer	0.000138	0.00339	CbGeAlD
Paclitaxel—ABCG2—mammalian vulva—uterine cancer	0.000134	0.00328	CbGeAlD
Paclitaxel—TUBB—lymph node—uterine cancer	0.000133	0.00327	CbGeAlD
Paclitaxel—CYP3A5—renal system—uterine cancer	0.000133	0.00326	CbGeAlD
Paclitaxel—TUBB2A—lymph node—uterine cancer	0.000133	0.00325	CbGeAlD
Paclitaxel—TUBB6—lymph node—uterine cancer	0.000131	0.00321	CbGeAlD
Paclitaxel—ABCG2—uterus—uterine cancer	0.000127	0.00313	CbGeAlD
Paclitaxel—ABCC1—female gonad—uterine cancer	0.000126	0.00309	CbGeAlD
Paclitaxel—ABCC1—vagina—uterine cancer	0.000125	0.00307	CbGeAlD
Paclitaxel—CYP2C8—female reproductive system—uterine cancer	0.000118	0.00289	CbGeAlD
Paclitaxel—ABCC10—lymph node—uterine cancer	0.000114	0.00281	CbGeAlD
Paclitaxel—TUBB4B—lymph node—uterine cancer	0.000114	0.00279	CbGeAlD
Paclitaxel—CYP2C8—vagina—uterine cancer	0.000107	0.00261	CbGeAlD
Paclitaxel—CYP2C9—female reproductive system—uterine cancer	0.000105	0.00257	CbGeAlD
Paclitaxel—ABCG2—female gonad—uterine cancer	0.000104	0.00256	CbGeAlD
Paclitaxel—ABCG2—vagina—uterine cancer	0.000104	0.00254	CbGeAlD
Paclitaxel—CYP3A4—renal system—uterine cancer	9.96e-05	0.00244	CbGeAlD
Paclitaxel—ABCB1—myometrium—uterine cancer	9.69e-05	0.00238	CbGeAlD
Paclitaxel—CYP3A5—female gonad—uterine cancer	9.67e-05	0.00237	CbGeAlD
Paclitaxel—CYP19A1—lymph node—uterine cancer	9.63e-05	0.00236	CbGeAlD
Paclitaxel—CYP3A5—vagina—uterine cancer	9.62e-05	0.00236	CbGeAlD
Paclitaxel—ABCC2—lymph node—uterine cancer	9.19e-05	0.00225	CbGeAlD
Paclitaxel—CYP1B1—lymph node—uterine cancer	9e-05	0.00221	CbGeAlD
Paclitaxel—ABCC1—lymph node—uterine cancer	8.09e-05	0.00199	CbGeAlD
Paclitaxel—CYP3A4—female reproductive system—uterine cancer	7.98e-05	0.00196	CbGeAlD
Paclitaxel—ABCB1—epithelium—uterine cancer	7.6e-05	0.00187	CbGeAlD
Paclitaxel—ABCB1—uterine cervix—uterine cancer	7.54e-05	0.00185	CbGeAlD
Paclitaxel—ABCB1—decidua—uterine cancer	7.18e-05	0.00176	CbGeAlD
Paclitaxel—ABCB1—renal system—uterine cancer	7.05e-05	0.00173	CbGeAlD
Paclitaxel—ABCB1—endometrium—uterine cancer	6.82e-05	0.00167	CbGeAlD
Paclitaxel—ABCG2—lymph node—uterine cancer	6.7e-05	0.00164	CbGeAlD
Paclitaxel—ABCB1—mammalian vulva—uterine cancer	6.6e-05	0.00162	CbGeAlD
Paclitaxel—ABCB1—uterus—uterine cancer	6.28e-05	0.00154	CbGeAlD
Paclitaxel—ABCB1—female reproductive system—uterine cancer	5.65e-05	0.00139	CbGeAlD
Paclitaxel—ABCB1—female gonad—uterine cancer	5.14e-05	0.00126	CbGeAlD
Paclitaxel—ABCB1—vagina—uterine cancer	5.11e-05	0.00125	CbGeAlD
Paclitaxel—ABCB1—lymph node—uterine cancer	3.3e-05	0.000811	CbGeAlD
Paclitaxel—Abdominal distension—Doxorubicin—uterine cancer	3.03e-05	0.00033	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Epirubicin—uterine cancer	3.02e-05	0.000329	CcSEcCtD
Paclitaxel—Dysphagia—Doxorubicin—uterine cancer	3.01e-05	0.000327	CcSEcCtD
Paclitaxel—Influenza—Doxorubicin—uterine cancer	3.01e-05	0.000327	CcSEcCtD
Paclitaxel—Pollakiuria—Epirubicin—uterine cancer	3.01e-05	0.000327	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Epirubicin—uterine cancer	2.97e-05	0.000323	CcSEcCtD
Paclitaxel—Paraesthesia—Etoposide—uterine cancer	2.96e-05	0.000322	CcSEcCtD
Paclitaxel—Weight increased—Epirubicin—uterine cancer	2.96e-05	0.000322	CcSEcCtD
Paclitaxel—Pancreatitis—Doxorubicin—uterine cancer	2.95e-05	0.000321	CcSEcCtD
Paclitaxel—Weight decreased—Epirubicin—uterine cancer	2.94e-05	0.00032	CcSEcCtD
Paclitaxel—Dyspnoea—Etoposide—uterine cancer	2.94e-05	0.00032	CcSEcCtD
Paclitaxel—Hyperglycaemia—Epirubicin—uterine cancer	2.94e-05	0.000319	CcSEcCtD
Paclitaxel—Somnolence—Etoposide—uterine cancer	2.94e-05	0.000319	CcSEcCtD
Paclitaxel—Pneumonia—Epirubicin—uterine cancer	2.92e-05	0.000317	CcSEcCtD
Paclitaxel—Infestation NOS—Epirubicin—uterine cancer	2.9e-05	0.000315	CcSEcCtD
Paclitaxel—Infestation—Epirubicin—uterine cancer	2.9e-05	0.000315	CcSEcCtD
Paclitaxel—Vomiting—Dactinomycin—uterine cancer	2.9e-05	0.000315	CcSEcCtD
Paclitaxel—Bronchitis—Doxorubicin—uterine cancer	2.9e-05	0.000315	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Epirubicin—uterine cancer	2.88e-05	0.000313	CcSEcCtD
Paclitaxel—Rash—Dactinomycin—uterine cancer	2.88e-05	0.000313	CcSEcCtD
Paclitaxel—Decreased appetite—Etoposide—uterine cancer	2.87e-05	0.000312	CcSEcCtD
Paclitaxel—Pancytopenia—Doxorubicin—uterine cancer	2.86e-05	0.000311	CcSEcCtD
Paclitaxel—Renal failure—Epirubicin—uterine cancer	2.85e-05	0.00031	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Etoposide—uterine cancer	2.85e-05	0.00031	CcSEcCtD
Paclitaxel—Fatigue—Etoposide—uterine cancer	2.85e-05	0.000309	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Epirubicin—uterine cancer	2.84e-05	0.000309	CcSEcCtD
Paclitaxel—Stomatitis—Epirubicin—uterine cancer	2.83e-05	0.000307	CcSEcCtD
Paclitaxel—Pain—Etoposide—uterine cancer	2.82e-05	0.000307	CcSEcCtD
Paclitaxel—Constipation—Etoposide—uterine cancer	2.82e-05	0.000307	CcSEcCtD
Paclitaxel—Conjunctivitis—Epirubicin—uterine cancer	2.82e-05	0.000307	CcSEcCtD
Paclitaxel—Urinary tract infection—Epirubicin—uterine cancer	2.82e-05	0.000307	CcSEcCtD
Paclitaxel—Dysuria—Doxorubicin—uterine cancer	2.82e-05	0.000306	CcSEcCtD
Paclitaxel—Neutropenia—Doxorubicin—uterine cancer	2.82e-05	0.000306	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Doxorubicin—uterine cancer	2.8e-05	0.000304	CcSEcCtD
Paclitaxel—Pollakiuria—Doxorubicin—uterine cancer	2.78e-05	0.000302	CcSEcCtD
Paclitaxel—Haematuria—Epirubicin—uterine cancer	2.77e-05	0.000301	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Doxorubicin—uterine cancer	2.75e-05	0.000299	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Epirubicin—uterine cancer	2.74e-05	0.000298	CcSEcCtD
Paclitaxel—Weight increased—Doxorubicin—uterine cancer	2.74e-05	0.000298	CcSEcCtD
Paclitaxel—Epistaxis—Epirubicin—uterine cancer	2.74e-05	0.000298	CcSEcCtD
Paclitaxel—Weight decreased—Doxorubicin—uterine cancer	2.72e-05	0.000296	CcSEcCtD
Paclitaxel—Sinusitis—Epirubicin—uterine cancer	2.72e-05	0.000296	CcSEcCtD
Paclitaxel—Feeling abnormal—Etoposide—uterine cancer	2.72e-05	0.000296	CcSEcCtD
Paclitaxel—Hyperglycaemia—Doxorubicin—uterine cancer	2.72e-05	0.000295	CcSEcCtD
Paclitaxel—Nausea—Dactinomycin—uterine cancer	2.71e-05	0.000295	CcSEcCtD
Paclitaxel—Pneumonia—Doxorubicin—uterine cancer	2.7e-05	0.000294	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Etoposide—uterine cancer	2.7e-05	0.000293	CcSEcCtD
Paclitaxel—Infestation—Doxorubicin—uterine cancer	2.69e-05	0.000292	CcSEcCtD
Paclitaxel—Infestation NOS—Doxorubicin—uterine cancer	2.69e-05	0.000292	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	2.66e-05	0.000289	CcSEcCtD
Paclitaxel—Bradycardia—Epirubicin—uterine cancer	2.65e-05	0.000288	CcSEcCtD
Paclitaxel—Renal failure—Doxorubicin—uterine cancer	2.64e-05	0.000287	CcSEcCtD
Paclitaxel—Neuropathy peripheral—Doxorubicin—uterine cancer	2.63e-05	0.000286	CcSEcCtD
Paclitaxel—Urticaria—Etoposide—uterine cancer	2.62e-05	0.000285	CcSEcCtD
Paclitaxel—Haemoglobin—Epirubicin—uterine cancer	2.62e-05	0.000285	CcSEcCtD
Paclitaxel—Stomatitis—Doxorubicin—uterine cancer	2.62e-05	0.000285	CcSEcCtD
Paclitaxel—Rhinitis—Epirubicin—uterine cancer	2.61e-05	0.000284	CcSEcCtD
Paclitaxel—Body temperature increased—Etoposide—uterine cancer	2.61e-05	0.000284	CcSEcCtD
Paclitaxel—Abdominal pain—Etoposide—uterine cancer	2.61e-05	0.000284	CcSEcCtD
Paclitaxel—Conjunctivitis—Doxorubicin—uterine cancer	2.61e-05	0.000284	CcSEcCtD
Paclitaxel—Urinary tract infection—Doxorubicin—uterine cancer	2.61e-05	0.000284	CcSEcCtD
Paclitaxel—Haemorrhage—Epirubicin—uterine cancer	2.61e-05	0.000283	CcSEcCtD
Paclitaxel—Hypoaesthesia—Epirubicin—uterine cancer	2.59e-05	0.000282	CcSEcCtD
Paclitaxel—Pharyngitis—Epirubicin—uterine cancer	2.59e-05	0.000281	CcSEcCtD
Paclitaxel—Urinary tract disorder—Epirubicin—uterine cancer	2.57e-05	0.00028	CcSEcCtD
Paclitaxel—Oedema peripheral—Epirubicin—uterine cancer	2.57e-05	0.000279	CcSEcCtD
Paclitaxel—Haematuria—Doxorubicin—uterine cancer	2.56e-05	0.000278	CcSEcCtD
Paclitaxel—Connective tissue disorder—Epirubicin—uterine cancer	2.56e-05	0.000278	CcSEcCtD
Paclitaxel—Urethral disorder—Epirubicin—uterine cancer	2.55e-05	0.000278	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Doxorubicin—uterine cancer	2.54e-05	0.000276	CcSEcCtD
Paclitaxel—Epistaxis—Doxorubicin—uterine cancer	2.53e-05	0.000275	CcSEcCtD
Paclitaxel—Sinusitis—Doxorubicin—uterine cancer	2.52e-05	0.000274	CcSEcCtD
Paclitaxel—Visual impairment—Epirubicin—uterine cancer	2.51e-05	0.000273	CcSEcCtD
Paclitaxel—Erythema multiforme—Epirubicin—uterine cancer	2.46e-05	0.000268	CcSEcCtD
Paclitaxel—Bradycardia—Doxorubicin—uterine cancer	2.45e-05	0.000267	CcSEcCtD
Paclitaxel—Eye disorder—Epirubicin—uterine cancer	2.43e-05	0.000265	CcSEcCtD
Paclitaxel—Hypersensitivity—Etoposide—uterine cancer	2.43e-05	0.000264	CcSEcCtD
Paclitaxel—Tinnitus—Epirubicin—uterine cancer	2.43e-05	0.000264	CcSEcCtD
Paclitaxel—Haemoglobin—Doxorubicin—uterine cancer	2.42e-05	0.000263	CcSEcCtD
Paclitaxel—Flushing—Epirubicin—uterine cancer	2.42e-05	0.000263	CcSEcCtD
Paclitaxel—Cardiac disorder—Epirubicin—uterine cancer	2.42e-05	0.000263	CcSEcCtD
Paclitaxel—Rhinitis—Doxorubicin—uterine cancer	2.42e-05	0.000263	CcSEcCtD
Paclitaxel—Haemorrhage—Doxorubicin—uterine cancer	2.41e-05	0.000262	CcSEcCtD
Paclitaxel—Hypoaesthesia—Doxorubicin—uterine cancer	2.4e-05	0.000261	CcSEcCtD
Paclitaxel—Pharyngitis—Doxorubicin—uterine cancer	2.39e-05	0.00026	CcSEcCtD
Paclitaxel—Urinary tract disorder—Doxorubicin—uterine cancer	2.38e-05	0.000259	CcSEcCtD
Paclitaxel—Oedema peripheral—Doxorubicin—uterine cancer	2.37e-05	0.000258	CcSEcCtD
Paclitaxel—Asthenia—Etoposide—uterine cancer	2.37e-05	0.000258	CcSEcCtD
Paclitaxel—Connective tissue disorder—Doxorubicin—uterine cancer	2.37e-05	0.000257	CcSEcCtD
Paclitaxel—Angiopathy—Epirubicin—uterine cancer	2.36e-05	0.000257	CcSEcCtD
Paclitaxel—Urethral disorder—Doxorubicin—uterine cancer	2.36e-05	0.000257	CcSEcCtD
Paclitaxel—Immune system disorder—Epirubicin—uterine cancer	2.35e-05	0.000256	CcSEcCtD
Paclitaxel—Mediastinal disorder—Epirubicin—uterine cancer	2.35e-05	0.000255	CcSEcCtD
Paclitaxel—Chills—Epirubicin—uterine cancer	2.34e-05	0.000254	CcSEcCtD
Paclitaxel—Pruritus—Etoposide—uterine cancer	2.34e-05	0.000254	CcSEcCtD
Paclitaxel—Arrhythmia—Epirubicin—uterine cancer	2.33e-05	0.000253	CcSEcCtD
Paclitaxel—Visual impairment—Doxorubicin—uterine cancer	2.32e-05	0.000253	CcSEcCtD
Paclitaxel—Alopecia—Epirubicin—uterine cancer	2.3e-05	0.00025	CcSEcCtD
Paclitaxel—Mental disorder—Epirubicin—uterine cancer	2.28e-05	0.000248	CcSEcCtD
Paclitaxel—Erythema multiforme—Doxorubicin—uterine cancer	2.28e-05	0.000248	CcSEcCtD
Paclitaxel—Erythema—Epirubicin—uterine cancer	2.27e-05	0.000247	CcSEcCtD
Paclitaxel—Malnutrition—Epirubicin—uterine cancer	2.27e-05	0.000247	CcSEcCtD
Paclitaxel—Diarrhoea—Etoposide—uterine cancer	2.26e-05	0.000246	CcSEcCtD
Paclitaxel—Eye disorder—Doxorubicin—uterine cancer	2.25e-05	0.000245	CcSEcCtD
Paclitaxel—Tinnitus—Doxorubicin—uterine cancer	2.25e-05	0.000244	CcSEcCtD
Paclitaxel—Flushing—Doxorubicin—uterine cancer	2.24e-05	0.000243	CcSEcCtD
Paclitaxel—Cardiac disorder—Doxorubicin—uterine cancer	2.24e-05	0.000243	CcSEcCtD
Paclitaxel—Flatulence—Epirubicin—uterine cancer	2.23e-05	0.000243	CcSEcCtD
Paclitaxel—Tension—Epirubicin—uterine cancer	2.23e-05	0.000242	CcSEcCtD
Paclitaxel—Dysgeusia—Epirubicin—uterine cancer	2.22e-05	0.000241	CcSEcCtD
Paclitaxel—Nervousness—Epirubicin—uterine cancer	2.2e-05	0.000239	CcSEcCtD
Paclitaxel—Back pain—Epirubicin—uterine cancer	2.19e-05	0.000238	CcSEcCtD
Paclitaxel—Angiopathy—Doxorubicin—uterine cancer	2.19e-05	0.000238	CcSEcCtD
Paclitaxel—Dizziness—Etoposide—uterine cancer	2.18e-05	0.000237	CcSEcCtD
Paclitaxel—Muscle spasms—Epirubicin—uterine cancer	2.18e-05	0.000237	CcSEcCtD
Paclitaxel—Immune system disorder—Doxorubicin—uterine cancer	2.18e-05	0.000237	CcSEcCtD
Paclitaxel—Mediastinal disorder—Doxorubicin—uterine cancer	2.17e-05	0.000236	CcSEcCtD
Paclitaxel—Chills—Doxorubicin—uterine cancer	2.16e-05	0.000235	CcSEcCtD
Paclitaxel—Arrhythmia—Doxorubicin—uterine cancer	2.15e-05	0.000234	CcSEcCtD
Paclitaxel—Vision blurred—Epirubicin—uterine cancer	2.14e-05	0.000232	CcSEcCtD
Paclitaxel—Alopecia—Doxorubicin—uterine cancer	2.13e-05	0.000232	CcSEcCtD
Paclitaxel—Mental disorder—Doxorubicin—uterine cancer	2.11e-05	0.00023	CcSEcCtD
Paclitaxel—Ill-defined disorder—Epirubicin—uterine cancer	2.1e-05	0.000229	CcSEcCtD
Paclitaxel—Vomiting—Etoposide—uterine cancer	2.1e-05	0.000228	CcSEcCtD
Paclitaxel—Malnutrition—Doxorubicin—uterine cancer	2.1e-05	0.000228	CcSEcCtD
Paclitaxel—Erythema—Doxorubicin—uterine cancer	2.1e-05	0.000228	CcSEcCtD
Paclitaxel—Anaemia—Epirubicin—uterine cancer	2.1e-05	0.000228	CcSEcCtD
Paclitaxel—Agitation—Epirubicin—uterine cancer	2.08e-05	0.000227	CcSEcCtD
Paclitaxel—Rash—Etoposide—uterine cancer	2.08e-05	0.000226	CcSEcCtD
Paclitaxel—Dermatitis—Etoposide—uterine cancer	2.08e-05	0.000226	CcSEcCtD
Paclitaxel—Headache—Etoposide—uterine cancer	2.07e-05	0.000225	CcSEcCtD
Paclitaxel—Flatulence—Doxorubicin—uterine cancer	2.07e-05	0.000225	CcSEcCtD
Paclitaxel—Tension—Doxorubicin—uterine cancer	2.06e-05	0.000224	CcSEcCtD
Paclitaxel—Dysgeusia—Doxorubicin—uterine cancer	2.05e-05	0.000223	CcSEcCtD
Paclitaxel—Malaise—Epirubicin—uterine cancer	2.04e-05	0.000222	CcSEcCtD
Paclitaxel—Nervousness—Doxorubicin—uterine cancer	2.04e-05	0.000222	CcSEcCtD
Paclitaxel—Vertigo—Epirubicin—uterine cancer	2.04e-05	0.000221	CcSEcCtD
Paclitaxel—Syncope—Epirubicin—uterine cancer	2.03e-05	0.000221	CcSEcCtD
Paclitaxel—Leukopenia—Epirubicin—uterine cancer	2.03e-05	0.000221	CcSEcCtD
Paclitaxel—Back pain—Doxorubicin—uterine cancer	2.03e-05	0.000221	CcSEcCtD
Paclitaxel—Muscle spasms—Doxorubicin—uterine cancer	2.02e-05	0.000219	CcSEcCtD
Paclitaxel—Palpitations—Epirubicin—uterine cancer	2e-05	0.000218	CcSEcCtD
Paclitaxel—Loss of consciousness—Epirubicin—uterine cancer	1.99e-05	0.000217	CcSEcCtD
Paclitaxel—Cough—Epirubicin—uterine cancer	1.98e-05	0.000215	CcSEcCtD
Paclitaxel—Vision blurred—Doxorubicin—uterine cancer	1.98e-05	0.000215	CcSEcCtD
Paclitaxel—Convulsion—Epirubicin—uterine cancer	1.96e-05	0.000214	CcSEcCtD
Paclitaxel—Nausea—Etoposide—uterine cancer	1.96e-05	0.000213	CcSEcCtD
Paclitaxel—Hypertension—Epirubicin—uterine cancer	1.96e-05	0.000213	CcSEcCtD
Paclitaxel—Ill-defined disorder—Doxorubicin—uterine cancer	1.95e-05	0.000212	CcSEcCtD
Paclitaxel—Anaemia—Doxorubicin—uterine cancer	1.94e-05	0.000211	CcSEcCtD
Paclitaxel—Arthralgia—Epirubicin—uterine cancer	1.93e-05	0.00021	CcSEcCtD
Paclitaxel—Chest pain—Epirubicin—uterine cancer	1.93e-05	0.00021	CcSEcCtD
Paclitaxel—Myalgia—Epirubicin—uterine cancer	1.93e-05	0.00021	CcSEcCtD
Paclitaxel—Agitation—Doxorubicin—uterine cancer	1.93e-05	0.00021	CcSEcCtD
Paclitaxel—Anxiety—Epirubicin—uterine cancer	1.92e-05	0.000209	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	1.92e-05	0.000208	CcSEcCtD
Paclitaxel—Discomfort—Epirubicin—uterine cancer	1.91e-05	0.000207	CcSEcCtD
Paclitaxel—Malaise—Doxorubicin—uterine cancer	1.89e-05	0.000206	CcSEcCtD
Paclitaxel—Dry mouth—Epirubicin—uterine cancer	1.89e-05	0.000205	CcSEcCtD
Paclitaxel—Vertigo—Doxorubicin—uterine cancer	1.89e-05	0.000205	CcSEcCtD
Paclitaxel—Syncope—Doxorubicin—uterine cancer	1.88e-05	0.000205	CcSEcCtD
Paclitaxel—Leukopenia—Doxorubicin—uterine cancer	1.88e-05	0.000204	CcSEcCtD
Paclitaxel—Confusional state—Epirubicin—uterine cancer	1.87e-05	0.000203	CcSEcCtD
Paclitaxel—Palpitations—Doxorubicin—uterine cancer	1.85e-05	0.000202	CcSEcCtD
Paclitaxel—Oedema—Epirubicin—uterine cancer	1.85e-05	0.000201	CcSEcCtD
Paclitaxel—Anaphylactic shock—Epirubicin—uterine cancer	1.85e-05	0.000201	CcSEcCtD
Paclitaxel—Loss of consciousness—Doxorubicin—uterine cancer	1.84e-05	0.0002	CcSEcCtD
Paclitaxel—Infection—Epirubicin—uterine cancer	1.84e-05	0.0002	CcSEcCtD
Paclitaxel—Cough—Doxorubicin—uterine cancer	1.83e-05	0.000199	CcSEcCtD
Paclitaxel—Shock—Epirubicin—uterine cancer	1.82e-05	0.000198	CcSEcCtD
Paclitaxel—Convulsion—Doxorubicin—uterine cancer	1.82e-05	0.000198	CcSEcCtD
Paclitaxel—Nervous system disorder—Epirubicin—uterine cancer	1.81e-05	0.000197	CcSEcCtD
Paclitaxel—Thrombocytopenia—Epirubicin—uterine cancer	1.81e-05	0.000197	CcSEcCtD
Paclitaxel—Hypertension—Doxorubicin—uterine cancer	1.81e-05	0.000197	CcSEcCtD
Paclitaxel—Tachycardia—Epirubicin—uterine cancer	1.81e-05	0.000196	CcSEcCtD
Paclitaxel—Skin disorder—Epirubicin—uterine cancer	1.8e-05	0.000195	CcSEcCtD
Paclitaxel—Hyperhidrosis—Epirubicin—uterine cancer	1.79e-05	0.000194	CcSEcCtD
Paclitaxel—Chest pain—Doxorubicin—uterine cancer	1.79e-05	0.000194	CcSEcCtD
Paclitaxel—Arthralgia—Doxorubicin—uterine cancer	1.79e-05	0.000194	CcSEcCtD
Paclitaxel—Myalgia—Doxorubicin—uterine cancer	1.79e-05	0.000194	CcSEcCtD
Paclitaxel—Anxiety—Doxorubicin—uterine cancer	1.78e-05	0.000194	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	1.77e-05	0.000193	CcSEcCtD
Paclitaxel—Discomfort—Doxorubicin—uterine cancer	1.76e-05	0.000192	CcSEcCtD
Paclitaxel—Anorexia—Epirubicin—uterine cancer	1.76e-05	0.000192	CcSEcCtD
Paclitaxel—Dry mouth—Doxorubicin—uterine cancer	1.75e-05	0.00019	CcSEcCtD
Paclitaxel—Hypotension—Epirubicin—uterine cancer	1.73e-05	0.000188	CcSEcCtD
Paclitaxel—Confusional state—Doxorubicin—uterine cancer	1.73e-05	0.000188	CcSEcCtD
Paclitaxel—Oedema—Doxorubicin—uterine cancer	1.71e-05	0.000186	CcSEcCtD
Paclitaxel—Anaphylactic shock—Doxorubicin—uterine cancer	1.71e-05	0.000186	CcSEcCtD
Paclitaxel—Infection—Doxorubicin—uterine cancer	1.7e-05	0.000185	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Epirubicin—uterine cancer	1.69e-05	0.000183	CcSEcCtD
Paclitaxel—Shock—Doxorubicin—uterine cancer	1.68e-05	0.000183	CcSEcCtD
Paclitaxel—Nervous system disorder—Doxorubicin—uterine cancer	1.68e-05	0.000183	CcSEcCtD
Paclitaxel—Thrombocytopenia—Doxorubicin—uterine cancer	1.68e-05	0.000182	CcSEcCtD
Paclitaxel—Insomnia—Epirubicin—uterine cancer	1.67e-05	0.000182	CcSEcCtD
Paclitaxel—Tachycardia—Doxorubicin—uterine cancer	1.67e-05	0.000182	CcSEcCtD
Paclitaxel—Skin disorder—Doxorubicin—uterine cancer	1.66e-05	0.000181	CcSEcCtD
Paclitaxel—Paraesthesia—Epirubicin—uterine cancer	1.66e-05	0.000181	CcSEcCtD
Paclitaxel—Hyperhidrosis—Doxorubicin—uterine cancer	1.66e-05	0.00018	CcSEcCtD
Paclitaxel—Dyspnoea—Epirubicin—uterine cancer	1.65e-05	0.000179	CcSEcCtD
Paclitaxel—Somnolence—Epirubicin—uterine cancer	1.65e-05	0.000179	CcSEcCtD
Paclitaxel—Anorexia—Doxorubicin—uterine cancer	1.63e-05	0.000177	CcSEcCtD
Paclitaxel—Dyspepsia—Epirubicin—uterine cancer	1.63e-05	0.000177	CcSEcCtD
Paclitaxel—Decreased appetite—Epirubicin—uterine cancer	1.61e-05	0.000175	CcSEcCtD
Paclitaxel—Hypotension—Doxorubicin—uterine cancer	1.6e-05	0.000174	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Epirubicin—uterine cancer	1.6e-05	0.000174	CcSEcCtD
Paclitaxel—Fatigue—Epirubicin—uterine cancer	1.6e-05	0.000173	CcSEcCtD
Paclitaxel—Pain—Epirubicin—uterine cancer	1.58e-05	0.000172	CcSEcCtD
Paclitaxel—Constipation—Epirubicin—uterine cancer	1.58e-05	0.000172	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Doxorubicin—uterine cancer	1.56e-05	0.00017	CcSEcCtD
Paclitaxel—Insomnia—Doxorubicin—uterine cancer	1.55e-05	0.000168	CcSEcCtD
Paclitaxel—Paraesthesia—Doxorubicin—uterine cancer	1.54e-05	0.000167	CcSEcCtD
Paclitaxel—Dyspnoea—Doxorubicin—uterine cancer	1.53e-05	0.000166	CcSEcCtD
Paclitaxel—Feeling abnormal—Epirubicin—uterine cancer	1.53e-05	0.000166	CcSEcCtD
Paclitaxel—Somnolence—Doxorubicin—uterine cancer	1.52e-05	0.000165	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Epirubicin—uterine cancer	1.51e-05	0.000165	CcSEcCtD
Paclitaxel—Dyspepsia—Doxorubicin—uterine cancer	1.51e-05	0.000164	CcSEcCtD
Paclitaxel—Decreased appetite—Doxorubicin—uterine cancer	1.49e-05	0.000162	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Doxorubicin—uterine cancer	1.48e-05	0.000161	CcSEcCtD
Paclitaxel—Fatigue—Doxorubicin—uterine cancer	1.48e-05	0.00016	CcSEcCtD
Paclitaxel—Urticaria—Epirubicin—uterine cancer	1.47e-05	0.00016	CcSEcCtD
Paclitaxel—Constipation—Doxorubicin—uterine cancer	1.46e-05	0.000159	CcSEcCtD
Paclitaxel—Pain—Doxorubicin—uterine cancer	1.46e-05	0.000159	CcSEcCtD
Paclitaxel—Abdominal pain—Epirubicin—uterine cancer	1.46e-05	0.000159	CcSEcCtD
Paclitaxel—Body temperature increased—Epirubicin—uterine cancer	1.46e-05	0.000159	CcSEcCtD
Paclitaxel—Feeling abnormal—Doxorubicin—uterine cancer	1.41e-05	0.000153	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Doxorubicin—uterine cancer	1.4e-05	0.000152	CcSEcCtD
Paclitaxel—Hypersensitivity—Epirubicin—uterine cancer	1.36e-05	0.000148	CcSEcCtD
Paclitaxel—Urticaria—Doxorubicin—uterine cancer	1.36e-05	0.000148	CcSEcCtD
Paclitaxel—Body temperature increased—Doxorubicin—uterine cancer	1.35e-05	0.000147	CcSEcCtD
Paclitaxel—Abdominal pain—Doxorubicin—uterine cancer	1.35e-05	0.000147	CcSEcCtD
Paclitaxel—Asthenia—Epirubicin—uterine cancer	1.33e-05	0.000144	CcSEcCtD
Paclitaxel—Pruritus—Epirubicin—uterine cancer	1.31e-05	0.000142	CcSEcCtD
Paclitaxel—Diarrhoea—Epirubicin—uterine cancer	1.27e-05	0.000138	CcSEcCtD
Paclitaxel—Hypersensitivity—Doxorubicin—uterine cancer	1.26e-05	0.000137	CcSEcCtD
Paclitaxel—Asthenia—Doxorubicin—uterine cancer	1.23e-05	0.000134	CcSEcCtD
Paclitaxel—Dizziness—Epirubicin—uterine cancer	1.22e-05	0.000133	CcSEcCtD
Paclitaxel—Pruritus—Doxorubicin—uterine cancer	1.21e-05	0.000132	CcSEcCtD
Paclitaxel—Vomiting—Epirubicin—uterine cancer	1.18e-05	0.000128	CcSEcCtD
Paclitaxel—Diarrhoea—Doxorubicin—uterine cancer	1.17e-05	0.000127	CcSEcCtD
Paclitaxel—Rash—Epirubicin—uterine cancer	1.17e-05	0.000127	CcSEcCtD
Paclitaxel—Dermatitis—Epirubicin—uterine cancer	1.17e-05	0.000127	CcSEcCtD
Paclitaxel—Headache—Epirubicin—uterine cancer	1.16e-05	0.000126	CcSEcCtD
Paclitaxel—Dizziness—Doxorubicin—uterine cancer	1.13e-05	0.000123	CcSEcCtD
Paclitaxel—Nausea—Epirubicin—uterine cancer	1.1e-05	0.00012	CcSEcCtD
Paclitaxel—Vomiting—Doxorubicin—uterine cancer	1.09e-05	0.000118	CcSEcCtD
Paclitaxel—Rash—Doxorubicin—uterine cancer	1.08e-05	0.000117	CcSEcCtD
Paclitaxel—Dermatitis—Doxorubicin—uterine cancer	1.08e-05	0.000117	CcSEcCtD
Paclitaxel—Headache—Doxorubicin—uterine cancer	1.07e-05	0.000117	CcSEcCtD
Paclitaxel—Nausea—Doxorubicin—uterine cancer	1.02e-05	0.000111	CcSEcCtD
Paclitaxel—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	8.56e-06	0.000183	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—CTNNB1—uterine cancer	8.48e-06	0.000181	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKR1C1—uterine cancer	8.48e-06	0.000181	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKR1C1—uterine cancer	8.44e-06	0.00018	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	8.44e-06	0.00018	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	8.42e-06	0.00018	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—CDKN1B—uterine cancer	8.37e-06	0.000179	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—EP300—uterine cancer	8.22e-06	0.000176	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—CTNNB1—uterine cancer	8.21e-06	0.000175	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKR1C1—uterine cancer	8.16e-06	0.000174	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—FGFR2—uterine cancer	8.15e-06	0.000174	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CDKN1B—uterine cancer	8.14e-06	0.000174	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—EP300—uterine cancer	8.04e-06	0.000172	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—CTNNB1—uterine cancer	8.03e-06	0.000171	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.97e-06	0.00017	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	7.95e-06	0.00017	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—POLD1—uterine cancer	7.94e-06	0.00017	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—POLD1—uterine cancer	7.87e-06	0.000168	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—CXCL8—uterine cancer	7.82e-06	0.000167	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKR1C3—uterine cancer	7.76e-06	0.000166	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CTNNB1—uterine cancer	7.69e-06	0.000164	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NDUFB11—uterine cancer	7.57e-06	0.000162	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SRD5A2—uterine cancer	7.57e-06	0.000162	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HMGA1—uterine cancer	7.56e-06	0.000161	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—RRM2—uterine cancer	7.56e-06	0.000161	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—RRM2—uterine cancer	7.52e-06	0.000161	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—PTEN—uterine cancer	7.49e-06	0.00016	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKR1C1—uterine cancer	7.43e-06	0.000159	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKR1C1—uterine cancer	7.36e-06	0.000157	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—EP300—uterine cancer	7.35e-06	0.000157	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—DCN—uterine cancer	7.33e-06	0.000157	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—DCN—uterine cancer	7.3e-06	0.000156	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	7.3e-06	0.000156	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—RRM2—uterine cancer	7.28e-06	0.000155	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKR1B1—uterine cancer	7.25e-06	0.000155	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—STAR—uterine cancer	7.25e-06	0.000155	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—CTNNB1—uterine cancer	7.21e-06	0.000154	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—STK11—uterine cancer	7.16e-06	0.000153	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CYP19A1—uterine cancer	7.16e-06	0.000153	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—CXCL8—uterine cancer	7.15e-06	0.000153	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—EP300—uterine cancer	7.14e-06	0.000153	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NDUFB11—uterine cancer	7.07e-06	0.000151	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SRD5A2—uterine cancer	7.07e-06	0.000151	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—DCN—uterine cancer	7.06e-06	0.000151	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TP53—uterine cancer	6.94e-06	0.000148	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—FBXW7—uterine cancer	6.91e-06	0.000148	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CYP11A1—uterine cancer	6.91e-06	0.000148	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP11A1—uterine cancer	6.88e-06	0.000147	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	6.87e-06	0.000147	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—STK11—uterine cancer	6.74e-06	0.000144	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CYP19A1—uterine cancer	6.74e-06	0.000144	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.72e-06	0.000143	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—NRAS—uterine cancer	6.68e-06	0.000143	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CYP11A1—uterine cancer	6.65e-06	0.000142	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—RRM2—uterine cancer	6.62e-06	0.000141	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—CTNNB1—uterine cancer	6.59e-06	0.000141	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—RRM2—uterine cancer	6.56e-06	0.00014	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKR1C3—uterine cancer	6.53e-06	0.000139	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKR1C3—uterine cancer	6.5e-06	0.000139	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	6.48e-06	0.000138	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—DCN—uterine cancer	6.43e-06	0.000137	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.41e-06	0.000137	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—DCN—uterine cancer	6.37e-06	0.000136	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	6.35e-06	0.000136	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.32e-06	0.000135	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKR1C3—uterine cancer	6.28e-06	0.000134	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKR1B1—uterine cancer	6.28e-06	0.000134	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—STAR—uterine cancer	6.28e-06	0.000134	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.21e-06	0.000133	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CDH1—uterine cancer	6.06e-06	0.000129	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP11A1—uterine cancer	6.05e-06	0.000129	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.03e-06	0.000129	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP11A1—uterine cancer	6e-06	0.000128	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	5.88e-06	0.000126	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TP53—uterine cancer	5.75e-06	0.000123	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—KRAS—uterine cancer	5.75e-06	0.000123	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKR1C3—uterine cancer	5.72e-06	0.000122	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—POLD1—uterine cancer	5.69e-06	0.000121	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKR1C3—uterine cancer	5.67e-06	0.000121	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	5.55e-06	0.000119	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKR1B1—uterine cancer	5.47e-06	0.000117	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—STAR—uterine cancer	5.47e-06	0.000117	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN2B—uterine cancer	5.42e-06	0.000116	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	5.41e-06	0.000116	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—MTHFR—uterine cancer	5.38e-06	0.000115	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKR1C1—uterine cancer	5.32e-06	0.000114	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—PIK3CA—uterine cancer	5.28e-06	0.000113	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—uterine cancer	5.26e-06	0.000112	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	5.16e-06	0.00011	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—ERBB2—uterine cancer	5.12e-06	0.000109	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKR1B1—uterine cancer	5.11e-06	0.000109	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—STAR—uterine cancer	5.11e-06	0.000109	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—STK11—uterine cancer	5.08e-06	0.000109	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—MTHFR—uterine cancer	5.06e-06	0.000108	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—STK11—uterine cancer	5.06e-06	0.000108	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP19A1—uterine cancer	5.06e-06	0.000108	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.05e-06	0.000108	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SMAD3—uterine cancer	4.95e-06	0.000106	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—POLD1—uterine cancer	4.93e-06	0.000105	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CYP19A1—uterine cancer	4.9e-06	0.000105	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—STK11—uterine cancer	4.9e-06	0.000105	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.89e-06	0.000104	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—HRAS—uterine cancer	4.89e-06	0.000104	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.77e-06	0.000102	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.75e-06	0.000101	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—RRM2—uterine cancer	4.74e-06	0.000101	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.74e-06	0.000101	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CDKN1B—uterine cancer	4.74e-06	0.000101	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—FGFR2—uterine cancer	4.72e-06	0.000101	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NDUFB11—uterine cancer	4.66e-06	9.95e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SRD5A2—uterine cancer	4.66e-06	9.95e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKR1C1—uterine cancer	4.61e-06	9.84e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—DCN—uterine cancer	4.6e-06	9.83e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.6e-06	9.81e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.55e-06	9.72e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MTHFR—uterine cancer	4.54e-06	9.7e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.53e-06	9.67e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CTNNB1—uterine cancer	4.48e-06	9.56e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.46e-06	9.53e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP19A1—uterine cancer	4.45e-06	9.51e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—STK11—uterine cancer	4.45e-06	9.51e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—STK11—uterine cancer	4.41e-06	9.43e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP19A1—uterine cancer	4.41e-06	9.43e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.38e-06	9.36e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PTEN—uterine cancer	4.36e-06	9.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP11A1—uterine cancer	4.34e-06	9.26e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—AKT1—uterine cancer	4.32e-06	9.22e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—POLD1—uterine cancer	4.29e-06	9.16e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EP300—uterine cancer	4.16e-06	8.88e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.16e-06	8.87e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—RRM2—uterine cancer	4.11e-06	8.77e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKR1C3—uterine cancer	4.1e-06	8.75e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKR1C1—uterine cancer	4.01e-06	8.57e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—POLD1—uterine cancer	4.01e-06	8.56e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—DCN—uterine cancer	3.99e-06	8.51e-05	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—AKT1—uterine cancer	3.97e-06	8.49e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NRAS—uterine cancer	3.89e-06	8.31e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—MTHFR—uterine cancer	3.82e-06	8.16e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.82e-06	8.15e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—MTHFR—uterine cancer	3.8e-06	8.12e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP11A1—uterine cancer	3.76e-06	8.02e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKR1C1—uterine cancer	3.75e-06	8.01e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.69e-06	7.89e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—MTHFR—uterine cancer	3.68e-06	7.85e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—RRM2—uterine cancer	3.58e-06	7.64e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKR1C3—uterine cancer	3.55e-06	7.58e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—DCN—uterine cancer	3.47e-06	7.42e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKR1B1—uterine cancer	3.37e-06	7.2e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—STAR—uterine cancer	3.37e-06	7.2e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.37e-06	7.19e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.35e-06	7.16e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KRAS—uterine cancer	3.35e-06	7.15e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—MTHFR—uterine cancer	3.35e-06	7.15e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—RRM2—uterine cancer	3.34e-06	7.14e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—MTHFR—uterine cancer	3.32e-06	7.08e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP11A1—uterine cancer	3.27e-06	6.99e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—DCN—uterine cancer	3.25e-06	6.93e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.24e-06	6.92e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—STK11—uterine cancer	3.19e-06	6.81e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP19A1—uterine cancer	3.19e-06	6.81e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.12e-06	6.66e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKR1C3—uterine cancer	3.09e-06	6.6e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PIK3CA—uterine cancer	3.08e-06	6.57e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP11A1—uterine cancer	3.06e-06	6.53e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTEN—uterine cancer	2.99e-06	6.39e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—ERBB2—uterine cancer	2.96e-06	6.33e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKR1C3—uterine cancer	2.89e-06	6.17e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—EP300—uterine cancer	2.85e-06	6.09e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HRAS—uterine cancer	2.85e-06	6.08e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTEN—uterine cancer	2.82e-06	6.01e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—STK11—uterine cancer	2.76e-06	5.9e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP19A1—uterine cancer	2.76e-06	5.9e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1B—uterine cancer	2.74e-06	5.86e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—EP300—uterine cancer	2.69e-06	5.74e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—POLD1—uterine cancer	2.64e-06	5.65e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.59e-06	5.54e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CTNNB1—uterine cancer	2.59e-06	5.53e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTEN—uterine cancer	2.53e-06	5.39e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AKT1—uterine cancer	2.51e-06	5.37e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.47e-06	5.28e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.47e-06	5.28e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EP300—uterine cancer	2.41e-06	5.14e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP19A1—uterine cancer	2.41e-06	5.14e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—STK11—uterine cancer	2.41e-06	5.14e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—MTHFR—uterine cancer	2.4e-06	5.12e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NRAS—uterine cancer	2.25e-06	4.81e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP19A1—uterine cancer	2.25e-06	4.8e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—STK11—uterine cancer	2.25e-06	4.8e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—RRM2—uterine cancer	2.2e-06	4.71e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—DCN—uterine cancer	2.14e-06	4.57e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTEN—uterine cancer	2.13e-06	4.54e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTEN—uterine cancer	2.12e-06	4.52e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.11e-06	4.51e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CA—uterine cancer	2.11e-06	4.51e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—MTHFR—uterine cancer	2.08e-06	4.43e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTEN—uterine cancer	2.05e-06	4.37e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—EP300—uterine cancer	2.03e-06	4.33e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—EP300—uterine cancer	2.02e-06	4.31e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.02e-06	4.31e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.01e-06	4.3e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CA—uterine cancer	1.99e-06	4.24e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—EP300—uterine cancer	1.95e-06	4.17e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—uterine cancer	1.94e-06	4.14e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.9e-06	4.07e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTEN—uterine cancer	1.86e-06	3.98e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTEN—uterine cancer	1.85e-06	3.94e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.83e-06	3.91e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—MTHFR—uterine cancer	1.81e-06	3.86e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CA—uterine cancer	1.78e-06	3.81e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—EP300—uterine cancer	1.78e-06	3.79e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—EP300—uterine cancer	1.76e-06	3.76e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AKT1—uterine cancer	1.72e-06	3.68e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—MTHFR—uterine cancer	1.69e-06	3.61e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HRAS—uterine cancer	1.65e-06	3.52e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AKT1—uterine cancer	1.62e-06	3.47e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CA—uterine cancer	1.5e-06	3.2e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CA—uterine cancer	1.49e-06	3.19e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.49e-06	3.18e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—STK11—uterine cancer	1.48e-06	3.17e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.48e-06	3.17e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT1—uterine cancer	1.46e-06	3.11e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CA—uterine cancer	1.44e-06	3.08e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTEN—uterine cancer	1.33e-06	2.85e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CA—uterine cancer	1.31e-06	2.8e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CA—uterine cancer	1.3e-06	2.78e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—EP300—uterine cancer	1.27e-06	2.72e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKT1—uterine cancer	1.22e-06	2.62e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKT1—uterine cancer	1.22e-06	2.6e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKT1—uterine cancer	1.18e-06	2.52e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTEN—uterine cancer	1.16e-06	2.47e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MTHFR—uterine cancer	1.11e-06	2.38e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—EP300—uterine cancer	1.1e-06	2.35e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKT1—uterine cancer	1.07e-06	2.29e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKT1—uterine cancer	1.06e-06	2.27e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTEN—uterine cancer	1.01e-06	2.15e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—EP300—uterine cancer	9.6e-07	2.05e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CA—uterine cancer	9.41e-07	2.01e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTEN—uterine cancer	9.4e-07	2.01e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—EP300—uterine cancer	8.97e-07	1.91e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CA—uterine cancer	8.15e-07	1.74e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKT1—uterine cancer	7.69e-07	1.64e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CA—uterine cancer	7.1e-07	1.52e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKT1—uterine cancer	6.66e-07	1.42e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CA—uterine cancer	6.63e-07	1.42e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTEN—uterine cancer	6.2e-07	1.32e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—EP300—uterine cancer	5.91e-07	1.26e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKT1—uterine cancer	5.8e-07	1.24e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKT1—uterine cancer	5.42e-07	1.16e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CA—uterine cancer	4.38e-07	9.34e-06	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKT1—uterine cancer	3.57e-07	7.63e-06	CbGpPWpGaD
